Publications by authors named "Myriam Holl"

Article Synopsis
  • * Research is looking into plasma-activated liquids (PAL) as a potential adjuvant treatment to reduce side effects and protect healthy tissue during peritoneal cancer therapy.
  • * Studies showed that human peritoneal macrophages exposed to PAL displayed resistance by increasing proliferation and anti-oxidative pathways, suggesting PAL might have beneficial immunomodulatory effects for treating peritoneal cancer.
View Article and Find Full Text PDF

(1) Background: Cervical intraepithelial neoplasia (CIN) of long-term persistence or associated with individual treatment indications often requires highly invasive treatments. These are associated with risks of bleeding, infertility, and pregnancy complications. For low- and middle-income countries (LMICs), standard treatment procedures are difficult to implement and manage.

View Article and Find Full Text PDF

Postoperative abdominal adhesions are responsible for serious clinical disorders. Administration of plasma-activated media (PAM) to cell type-specific modulated proliferation and protein biosynthesis is a promising therapeutic strategy to prevent pathological cell responses in the context of wound healing disorders. We analyzed PAM as a therapeutic option based on cell type-specific anti-adhesive responses.

View Article and Find Full Text PDF

Peritoneal mucosa of mesothelial cells line the abdominal cavity, surround intestinal organs and the female reproductive organs and are responsible for immunological integrity, organ functionality and regeneration. Peritoneal diseases range from inflammation, adhesions, endometriosis, and cancer. Efficient technologies to isolate and cultivate healthy patient-derived mesothelial cells with maximal purity enable the generation of capable 2D and 3D as well as in vivo-like microfluidic cell culture models to investigate pathomechanisms and treatment strategies.

View Article and Find Full Text PDF